Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs
Global regulatory affairs leader with 30 years in the pharmaceutical industry, including 28 years in regulatory affairs spanning development, registration,